Mortara Instrument, a provider of ECG technology, has entered into a definitive agreement to buy Cardiac Science's diagnostic cardiology product line for an undisclosed sum.
The transaction will include Cardiac Science's Burdick and Quinton brands and associated products but excludes the MySense single-patient ECG Recorder system and the resuscitation business unit that markets automated external defibrillators (AEDs).
Cardiac Science CEO Neal Long said divesting the diagnostic cardiology product line will bring more strategic focus to the company.
"The company will now be able to exclusively focus on innovation and the expansion of market share in its high margin resuscitation business," Long said.
Customers of Cardiac Science will also continue to receive technical, sales and service through the existing channels until they are notified otherwise.
Mortara Instrument CEO Dr Justin Mortara said the addition of the businesses will accelerate the introduction of the company's ECG technology to new markets.
"As a historic technology supplier to both Burdick and Quinton, we hold an enormous amount of respect for the people and the products behind these established names," Mortara said.
"We look forward to marrying our ECG expertise with these powerful brands and the know-how behind them to create exciting new solutions for our customers."
Cardiac Science, an Opto Circuits group company, also manufactures electrocardiograph devices (ECG/EKG), cardiac stress treadmills and systems, diagnostic workstations, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry, Holter monitoring and cardiology data management systems.